BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Fibrosis
1
Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source
9/7/2019 4:43:36 AM | Browse: 16 | Download: 30
2
Layered enhancement at magnetic resonance enterography in inflammatory bowel disease: A meta-analysis
8/21/2019 9:19:18 AM | Browse: 36 | Download: 26
3
Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease
7/28/2019 10:51:57 AM | Browse: 29 | Download: 9
4
Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets
7/6/2019 6:23:58 AM | Browse: 39 | Download: 15
5
Roles of hepatic stellate cells in acute liver failure: From the perspective of inflammation and fibrosis
5/27/2019 8:24:36 AM | Browse: 46 | Download: 36
6
Effectiveness of venous thromboembolism prophylaxis in patients with liver disease
4/26/2019 3:40:00 AM | Browse: 64 | Download: 34
7
Repurposing drugs to target nonalcoholic steatohepatitis
4/18/2019 5:48:09 AM | Browse: 74 | Download: 24
8
Persistent elevation of fibrosis biomarker cartilage oligomeric matrix protein following hepatitis C virus eradication
3/27/2019 10:37:20 AM | Browse: 73 | Download: 70
9
Diffusion-weighted magnetic resonance imaging and micro-RNA in the diagnosis of hepatic fibrosis in chronic hepatitis C virus
3/20/2019 5:32:10 AM | Browse: 87 | Download: 56
10
Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice
3/20/2019 5:32:10 AM | Browse: 74 | Download: 42
11
Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects
2/26/2019 11:29:04 AM | Browse: 90 | Download: 38
12
Human immunodeficiency virus and hepatotropic viruses co-morbidities as the inducers of liver injury progression
1/26/2019 11:40:14 AM | Browse: 107 | Download: 29
13
Correlation analysis of collagen proportionate area in Budd-Chiari syndrome: A preliminary clinicopathological study
1/26/2019 8:24:19 AM | Browse: 61 | Download: 44
14
Current status, problems, and perspectives of non-alcoholic fatty liver disease research
1/14/2019 2:54:12 PM | Browse: 153 | Download: 73
15
Role of cenicriviroc in the management of nonalcoholic fatty liver disease
12/27/2018 8:56:32 AM | Browse: 95 | Download: 47
16
Management of local recurrence after endoscopic resection of neoplastic colonic polyps
12/21/2018 6:09:14 AM | Browse: 108 | Download: 69
17
Liver as a target of human immunodeficiency virus infection
11/13/2018 8:04:45 AM | Browse: 146 | Download: 66
18
Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer
10/18/2018 10:13:24 AM | Browse: 114 | Download: 58
19
A small molecule fibrokinase inhibitor in a model of fibropolycystic hepatorenal disease
9/7/2018 9:21:44 AM | Browse: 144 | Download: 76
20
Polycystic kidney and hepatic disease 1 gene mutations in von Meyenburg complexes: Case report
9/7/2018 1:56:18 AM | Browse: 112 | Download: 49
21
Liver intravoxel incoherent motion diffusion-weighted imaging for the assessment of hepatic steatosis and fibrosis in children
7/19/2018 7:04:34 AM | Browse: 197 | Download: 136
22
Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions
6/28/2018 2:47:35 AM | Browse: 224 | Download: 118
23
Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction
4/27/2018 3:25:40 AM | Browse: 241 | Download: 89
24
Beneficial effects of naringenin in liver diseases: Molecular mechanisms
4/27/2018 3:25:40 AM | Browse: 235 | Download: 115
25
Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity
4/19/2018 7:56:07 AM | Browse: 184 | Download: 89
26
Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals
3/16/2018 12:27:25 PM | Browse: 220 | Download: 88
27
Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease
3/16/2018 12:27:25 PM | Browse: 210 | Download: 67
28
Collagen proportionate area correlates to hepatic venous pressure gradient in non-abstinent cirrhotic patients with alcoholic liver disease
1/26/2018 8:09:36 AM | Browse: 233 | Download: 153
29
Role of inflammatory response in liver diseases: Therapeutic strategies
1/26/2018 8:09:36 AM | Browse: 297 | Download: 157
30
Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis
1/14/2018 5:07:58 AM | Browse: 330 | Download: 139
31
Antifibrogenic effects of vitamin D derivatives on mouse pancreatic stellate cells
1/14/2018 5:07:58 AM | Browse: 224 | Download: 96
32
Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection
12/27/2017 10:31:19 AM | Browse: 249 | Download: 96
33
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
12/20/2017 2:49:19 AM | Browse: 242 | Download: 125
34
Pathological process of liver sinusoidal endothelial cells in liver diseases
11/20/2017 4:03:35 AM | Browse: 318 | Download: 136
35
Risk of liver disease in methotrexate treated patients
9/15/2017 5:43:48 AM | Browse: 305 | Download: 192
36
Expression of matrix metalloproteinase-11 is increased under conditions of insulin resistance
9/13/2017 7:36:12 AM | Browse: 261 | Download: 175
37
CD4+ T cells and natural killer cells: Biomarkers for hepatic fibrosis in human immunodeficiency virus/hepatitis C virus-coinfected patients
9/7/2017 2:39:18 AM | Browse: 243 | Download: 244
38
Fibrinogen deficiency suppresses the development of early and delayed radiation enteropathy
7/12/2017 6:45:23 AM | Browse: 268 | Download: 215
39
Impact of hepatitis C oral therapy in portal hypertension
7/12/2017 6:45:23 AM | Browse: 311 | Download: 507
40
Naringenin prevents experimental liver fibrosis by blocking TGFβ-Smad3 and JNK-Smad3 pathways
6/26/2017 10:23:06 AM | Browse: 253 | Download: 228
41
Cardiac damage in athlete’s heart: When the “supernormal” heart fails!
6/26/2017 12:49:43 AM | Browse: 254 | Download: 178
42
Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease
6/20/2017 12:12:52 PM | Browse: 313 | Download: 484
43
Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis
6/14/2017 9:25:57 AM | Browse: 300 | Download: 261
44
Embrionary way to create a fatty liver in portal hypertension
5/16/2017 6:56:36 AM | Browse: 467 | Download: 378
45
Non-invasive evaluation of intestinal disorders: The role of elastographic techniques
4/28/2017 10:26:16 AM | Browse: 290 | Download: 423
46
Proton pump inhibitor induced collagen expression in colonocytes is associated with collagenous colitis
3/6/2017 1:27:00 PM | Browse: 273 | Download: 443
47
Fibrosis assessment using FibroMeter combined to first generation tests in hepatitis C
2/27/2017 8:50:00 AM | Browse: 288 | Download: 374
48
Association between endotoxemia and histological features of nonalcoholic fatty liver disease
1/19/2017 11:16:00 AM | Browse: 650 | Download: 461
49
Predictors for advanced fibrosis in morbidly obese non-alcoholic fatty liver patients
1/16/2017 10:39:00 AM | Browse: 301 | Download: 283
50
Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trial
1/5/2017 11:10:00 AM | Browse: 436 | Download: 586